University of Utah Health, Salt Lake City, and Intermountain Healthcare, Murray, Utah.
Corresponding author: Ann M. Bruno, MD, MS, Department of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, UT; email: [email protected].
Financial Disclosure Outside of the submitted work, Torri D. Metz reports personal fees from Pfizer for her role as a medical consultant for a SARS-CoV-2 vaccination in pregnancy study, grants from Pfizer for role as a site PI for SARS-CoV-2 vaccination in pregnancy study, grants from Pfizer for role as a site PI for RSV vaccination in pregnancy study, and grants from Gestvision for role as a site PI for a preeclampsia study. She also reports receiving UpToDate royalties for two topics on trial of labor after cesarean. Michelle L. Debbink reports receiving salary support from the American Board of Obstetrics and Gynecology and the March of Dimes as part of the Reproductive Scientist Development Program. Marcela C. Smid serves as a medical consultant for Gilead Science Incorporated, Organon Inc., and the American Academy of Addiction Psychiatry. Dr. Smid also receives funding from National Institute on Drug Abuse and the Centers for Disease Control and Prevention. The other authors did not report any potential conflicts of interest.
The authors thank the University of Utah Department of Surgery and the Surgical Population Analysis Research Core for its role in facilitating data collection, database management, and analysis.
Torri D. Metz, Deputy Editor (Obstetrics) of Obstetrics & Gynecology, was not involved in the review or decision to publish this article.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/C993.
